nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—Carbetocin—OXTR—lung cancer	0.0706	0.972	CrCbGaD
Vapreotide—Desmopressin—PTGS2—lung cancer	0.00203	0.028	CrCbGaD
Vapreotide—TACR1—Signaling Pathways—AKR1C1—lung cancer	0.000872	0.00094	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GRP—lung cancer	0.000872	0.00094	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTHLH—lung cancer	0.000866	0.000934	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FLT1—lung cancer	0.000855	0.000922	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CG—lung cancer	0.000847	0.000913	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOTCH3—lung cancer	0.000837	0.000902	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APP—lung cancer	0.000837	0.000902	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000834	0.0009	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGF9—lung cancer	0.00083	0.000895	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNG11—lung cancer	0.000816	0.00088	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ANXA1—lung cancer	0.000815	0.000878	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—POMC—lung cancer	0.000806	0.000869	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL8—lung cancer	0.000802	0.000865	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AVP—lung cancer	0.0008	0.000863	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000799	0.000861	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JUNB—lung cancer	0.000792	0.000854	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FLT1—lung cancer	0.000789	0.000851	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CG—lung cancer	0.000782	0.000843	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VEGFC—lung cancer	0.000777	0.000838	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APP—lung cancer	0.000772	0.000833	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOTCH3—lung cancer	0.000772	0.000833	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CG—lung cancer	0.000769	0.000829	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGF9—lung cancer	0.000766	0.000826	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CD—lung cancer	0.000744	0.000803	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—POMC—lung cancer	0.000744	0.000802	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADCY1—lung cancer	0.000734	0.000791	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—POMC—lung cancer	0.000732	0.000789	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JUNB—lung cancer	0.000731	0.000789	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STK11—lung cancer	0.00072	0.000776	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PPP2R1B—lung cancer	0.000715	0.000771	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SMARCA4—lung cancer	0.000715	0.000771	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6R—lung cancer	0.000714	0.00077	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CG—lung cancer	0.00071	0.000765	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FOXO3—lung cancer	0.000694	0.000749	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HSPB1—lung cancer	0.00069	0.000744	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CD—lung cancer	0.000687	0.000741	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTHLH—lung cancer	0.000682	0.000736	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MAP2K1—lung cancer	0.000681	0.000734	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CD—lung cancer	0.000676	0.000729	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—POMC—lung cancer	0.000676	0.000728	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STK11—lung cancer	0.000664	0.000716	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6R—lung cancer	0.000659	0.000711	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AVP—lung cancer	0.000651	0.000702	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CB—lung cancer	0.000649	0.0007	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ANXA1—lung cancer	0.000641	0.000692	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FOXO3—lung cancer	0.000641	0.000691	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MAP2K1—lung cancer	0.000628	0.000677	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF1R—lung cancer	0.000626	0.000675	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CD—lung cancer	0.000624	0.000673	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL8—lung cancer	0.000624	0.000672	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FLT1—lung cancer	0.000621	0.00067	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HES1—lung cancer	0.000615	0.000664	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CG—lung cancer	0.000615	0.000663	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOTCH3—lung cancer	0.000608	0.000656	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APP—lung cancer	0.000608	0.000656	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—RAF1—lung cancer	0.000604	0.000651	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGF9—lung cancer	0.000603	0.00065	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AVP—lung cancer	0.000601	0.000648	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CB—lung cancer	0.000599	0.000646	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2—lung cancer	0.000596	0.000643	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CB—lung cancer	0.000589	0.000635	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—POMC—lung cancer	0.000586	0.000632	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF1R—lung cancer	0.000578	0.000623	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JUNB—lung cancer	0.000576	0.000621	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL8—lung cancer	0.000575	0.000621	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HES1—lung cancer	0.000568	0.000612	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL8—lung cancer	0.000566	0.000611	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ERBB3—lung cancer	0.000563	0.000607	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CG—lung cancer	0.000559	0.000603	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—RAF1—lung cancer	0.000557	0.000601	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2—lung cancer	0.00055	0.000593	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CB—lung cancer	0.000544	0.000586	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2—lung cancer	0.000541	0.000584	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CD—lung cancer	0.000541	0.000583	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TERT—lung cancer	0.000539	0.000581	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—POMC—lung cancer	0.000532	0.000574	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGFR1—lung cancer	0.000524	0.000565	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STK11—lung cancer	0.000523	0.000564	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL8—lung cancer	0.000523	0.000564	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ERBB3—lung cancer	0.000519	0.00056	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6R—lung cancer	0.000519	0.000559	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HIF1A—lung cancer	0.000516	0.000556	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FOXO3—lung cancer	0.000505	0.000544	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2—lung cancer	0.000499	0.000539	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOA1—lung cancer	0.000498	0.000537	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TERT—lung cancer	0.000498	0.000537	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MAP2K1—lung cancer	0.000494	0.000533	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KDR—lung cancer	0.000493	0.000532	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CD—lung cancer	0.000491	0.00053	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGFR1—lung cancer	0.000483	0.000521	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HIF1A—lung cancer	0.000476	0.000513	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AVP—lung cancer	0.000473	0.00051	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CB—lung cancer	0.000471	0.000508	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOA1—lung cancer	0.000459	0.000495	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KDR—lung cancer	0.000455	0.000491	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF1R—lung cancer	0.000455	0.000491	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KIT—lung cancer	0.000454	0.00049	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APC—lung cancer	0.000454	0.00049	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CG—lung cancer	0.000454	0.00049	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—NRAS—lung cancer	0.000454	0.00049	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL8—lung cancer	0.000453	0.000489	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EGF—lung cancer	0.000449	0.000484	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HES1—lung cancer	0.000447	0.000482	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—RAF1—lung cancer	0.000439	0.000473	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MAPK3—lung cancer	0.000435	0.000469	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2—lung cancer	0.000433	0.000467	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—POMC—lung cancer	0.000432	0.000466	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CB—lung cancer	0.000428	0.000462	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—BRAF—lung cancer	0.000427	0.00046	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6R—lung cancer	0.000422	0.000455	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CREBBP—lung cancer	0.000421	0.000454	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CG—lung cancer	0.000419	0.000452	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KIT—lung cancer	0.000419	0.000452	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APC—lung cancer	0.000419	0.000452	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—NRAS—lung cancer	0.000419	0.000452	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EGF—lung cancer	0.000414	0.000447	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—EGFR—lung cancer	0.000414	0.000446	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL8—lung cancer	0.000411	0.000444	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ERBB3—lung cancer	0.000409	0.000441	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAP2K1—lung cancer	0.000402	0.000433	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MAPK3—lung cancer	0.000402	0.000433	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CD—lung cancer	0.000399	0.000431	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—POMC—lung cancer	0.000399	0.00043	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CA—lung cancer	0.000396	0.000427	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—BRAF—lung cancer	0.000394	0.000425	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2—lung cancer	0.000393	0.000424	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TERT—lung cancer	0.000392	0.000422	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—KRAS—lung cancer	0.000391	0.000422	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6R—lung cancer	0.000389	0.00042	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CREBBP—lung cancer	0.000389	0.000419	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—EGFR—lung cancer	0.000382	0.000412	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGFR1—lung cancer	0.00038	0.00041	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HIF1A—lung cancer	0.000375	0.000404	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAP2K1—lung cancer	0.000371	0.0004	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CD—lung cancer	0.000369	0.000397	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CA—lung cancer	0.000365	0.000394	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOA1—lung cancer	0.000362	0.00039	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—KRAS—lung cancer	0.000361	0.000389	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CA—lung cancer	0.000359	0.000387	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KDR—lung cancer	0.000358	0.000386	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MDM2—lung cancer	0.000358	0.000386	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RAF1—lung cancer	0.000357	0.000384	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ERBB2—lung cancer	0.000353	0.00038	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CB—lung cancer	0.000348	0.000375	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MTOR—lung cancer	0.000348	0.000375	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL8—lung cancer	0.000335	0.000361	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HRAS—lung cancer	0.000332	0.000358	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CA—lung cancer	0.000332	0.000357	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MDM2—lung cancer	0.00033	0.000356	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KIT—lung cancer	0.00033	0.000356	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APC—lung cancer	0.00033	0.000356	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CG—lung cancer	0.00033	0.000356	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—NRAS—lung cancer	0.00033	0.000356	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RAF1—lung cancer	0.000329	0.000355	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EGF—lung cancer	0.000326	0.000352	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ERBB2—lung cancer	0.000326	0.000351	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AKT1—lung cancer	0.000323	0.000348	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CB—lung cancer	0.000321	0.000346	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MTOR—lung cancer	0.000321	0.000346	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CASP3—lung cancer	0.00032	0.000345	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2—lung cancer	0.00032	0.000345	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—lung cancer	0.000318	0.000343	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MAPK3—lung cancer	0.000316	0.000341	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—POMC—lung cancer	0.000314	0.000339	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCND1—lung cancer	0.000312	0.000336	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JUN—lung cancer	0.000311	0.000335	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—BRAF—lung cancer	0.00031	0.000335	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL8—lung cancer	0.000309	0.000333	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HRAS—lung cancer	0.000307	0.000331	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6R—lung cancer	0.000307	0.00033	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CREBBP—lung cancer	0.000306	0.00033	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—lung cancer	0.000303	0.000326	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN1A—lung cancer	0.000301	0.000325	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTEN—lung cancer	0.000301	0.000324	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—EGFR—lung cancer	0.000301	0.000324	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKT1—lung cancer	0.000298	0.000322	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CASP3—lung cancer	0.000295	0.000319	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2—lung cancer	0.000295	0.000318	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—lung cancer	0.000294	0.000317	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKT1—lung cancer	0.000293	0.000316	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAP2K1—lung cancer	0.000292	0.000315	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CD—lung cancer	0.00029	0.000313	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCND1—lung cancer	0.000288	0.00031	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CA—lung cancer	0.000287	0.00031	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JUN—lung cancer	0.000287	0.000309	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EP300—lung cancer	0.000287	0.000309	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—KRAS—lung cancer	0.000284	0.000306	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—lung cancer	0.000279	0.000301	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SRC—lung cancer	0.000279	0.000301	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN1A—lung cancer	0.000278	0.0003	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTEN—lung cancer	0.000278	0.000299	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VEGFA—lung cancer	0.000272	0.000293	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKT1—lung cancer	0.000271	0.000292	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STAT3—lung cancer	0.000269	0.00029	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NRAS—lung cancer	0.000268	0.000289	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EP300—lung cancer	0.000265	0.000285	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CA—lung cancer	0.000261	0.000281	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MDM2—lung cancer	0.00026	0.00028	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RAF1—lung cancer	0.000259	0.000279	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SRC—lung cancer	0.000257	0.000278	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK3—lung cancer	0.000257	0.000277	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ERBB2—lung cancer	0.000256	0.000276	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CB—lung cancer	0.000253	0.000273	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MTOR—lung cancer	0.000253	0.000273	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VEGFA—lung cancer	0.000251	0.00027	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MYC—lung cancer	0.00025	0.00027	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STAT3—lung cancer	0.000248	0.000268	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NRAS—lung cancer	0.000248	0.000267	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EGFR—lung cancer	0.000245	0.000264	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL8—lung cancer	0.000243	0.000262	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HRAS—lung cancer	0.000241	0.00026	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK3—lung cancer	0.000237	0.000256	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKT1—lung cancer	0.000235	0.000253	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CASP3—lung cancer	0.000233	0.000251	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2—lung cancer	0.000232	0.00025	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—lung cancer	0.000231	0.000249	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KRAS—lung cancer	0.000231	0.000249	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MYC—lung cancer	0.000231	0.000249	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCND1—lung cancer	0.000226	0.000244	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JUN—lung cancer	0.000226	0.000244	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EGFR—lung cancer	0.000226	0.000243	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—lung cancer	0.00022	0.000237	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN1A—lung cancer	0.000219	0.000236	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTEN—lung cancer	0.000219	0.000236	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKT1—lung cancer	0.000213	0.00023	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KRAS—lung cancer	0.000213	0.00023	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CA—lung cancer	0.000212	0.000229	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EP300—lung cancer	0.000208	0.000225	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TP53—lung cancer	0.000205	0.000221	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SRC—lung cancer	0.000203	0.000219	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VEGFA—lung cancer	0.000197	0.000213	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HRAS—lung cancer	0.000196	0.000212	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CA—lung cancer	0.000196	0.000211	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STAT3—lung cancer	0.000195	0.000211	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NRAS—lung cancer	0.000195	0.00021	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TP53—lung cancer	0.000189	0.000204	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—lung cancer	0.000188	0.000203	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK3—lung cancer	0.000187	0.000201	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MYC—lung cancer	0.000182	0.000196	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HRAS—lung cancer	0.000181	0.000195	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EGFR—lung cancer	0.000178	0.000192	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—lung cancer	0.000173	0.000187	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKT1—lung cancer	0.000173	0.000187	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KRAS—lung cancer	0.000168	0.000181	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT1—lung cancer	0.00016	0.000173	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CA—lung cancer	0.000154	0.000166	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TP53—lung cancer	0.000149	0.000161	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HRAS—lung cancer	0.000143	0.000154	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—lung cancer	0.000137	0.000147	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT1—lung cancer	0.000126	0.000136	CbGpPWpGaD
